Junichi Hayashi Selected Research

Junichi Hayashi Research Topics

Disease

3	Myocardial Infarction 08/2010 - 05/2002
3	Infarction (Infarctions) 07/2003 - 05/2002
2	Infections 03/2022 - 02/2010
2	Insulin Resistance 01/2011 - 06/2009
2	Ischemia 03/2006 - 01/2003
1	Glomerulonephritis 03/2022
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 03/2022
1	Nephritis 03/2022
1	Hypoxia (Hypoxemia) 02/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2021
1	Lung Diseases (Lung Disease) 02/2021
1	Amyopathic dermatomyositis 02/2021
1	Respiratory Insufficiency (Respiratory Failure) 02/2021
1	Rheumatoid Arthritis 11/2019
1	Membranous Glomerulonephritis (Membranous Nephropathy) 11/2019
1	Proteinuria 11/2019
1	Fatigue 03/2015
1	Atherosclerosis 02/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2013
1	Neoplasms (Cancer) 10/2010
1	Lung Neoplasms (Lung Cancer) 10/2010
1	Inflammation (Inflammations) 08/2010
1	Myocarditis (Carditis) 08/2010
1	Adenocarcinoma 07/2010
1	Type 2 Diabetes Mellitus (MODY) 06/2009
1	Hypercholesterolemia 12/2006
1	Chronic Limb-Threatening Ischemia 03/2006
1	Peripheral Arterial Disease 03/2006
1	Hyperplasia 12/2005
1	Fever (Fevers) 11/2005
1	Abscess 11/2005
1	Brugada Syndrome 03/2005
1	Sudden Death 03/2005
1	Aortic Dissection 11/2003

Drug/Important Bio-Agent (IBA)

3	Messenger RNA (mRNA)IBA 07/2003 - 05/2002
2	ErbB Receptors (EGF Receptor)IBA 07/2010 - 05/2002
1	TinIBA 03/2022
1	Fibrinolysin FDA Link 03/2022
1	plasmin receptorIBA 03/2022
1	erythrogenic toxinIBA 03/2022
1	Polymyxin B (Aerosporin)FDA LinkGeneric 02/2021
1	Calcineurin InhibitorsIBA 02/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021
1	Prednisolone (Predate)FDA LinkGeneric 11/2019
1	Antirheumatic Agents (DMARD)IBA 11/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 11/2019
1	alpha-Tocopherol FDA Link 03/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2015
1	Vitamin E FDA LinkGeneric 03/2015
1	sesaminIBA 03/2015
1	LignansIBA 03/2015
1	LDL CholesterolIBA 02/2015
1	Interleukin-15 (Interleukin 15)IBA 01/2011
1	CytokinesIBA 08/2010
1	HepcidinsIBA 08/2010
1	Free RadicalsIBA 08/2010
1	IronIBA 08/2010
1	Peptide Hormones (Polypeptide Hormones)IBA 08/2010
1	Biological ProductsIBA 07/2010
1	PPAR-gamma AgonistsIBA 06/2009
1	Pioglitazone (Actos)FDA Link 06/2009
1	Arginine (L-Arginine)FDA Link 12/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2006
1	8-bromocyclic GMPIBA 12/2006
1	CholesterolIBA 12/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2006
1	Talaporfin (talaporfin sodium)IBA 12/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2005
1	Gallium-67IBA 11/2005
1	OsteopontinIBA 07/2003
1	Collagen Type I (Type I Collagen)IBA 07/2003
1	OsteonectinIBA 07/2003
1	ChloridesIBA 01/2003
1	Proteins (Proteins, Gene)FDA Link 01/2003
1	Bone Morphogenetic Protein 7IBA 01/2003
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2003
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2002
1	Epidermal Growth Factor (EGF)IBA 05/2002
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 05/2002
1	Heparin (Liquaemin)FDA LinkGeneric 05/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2002
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 05/2002

Therapy/Procedure

4	Therapeutics 02/2021 - 11/2005
1	Hemoperfusion 02/2021
1	Plasma Exchange 02/2021
1	Critical Care (Surgical Intensive Care) 02/2021
1	Radiotherapy 07/2013
1	Aftercare (After-Treatment) 10/2010
1	Segmental Mastectomy (Lumpectomy) 10/2010
1	Thoracotomy 02/2010
1	Blalock-Taussig Procedure 02/2010
1	Glycemic Control 06/2009
1	Photochemotherapy (Photodynamic Therapy) 12/2005
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 03/2005
1	Stents 11/2003